-
2024-512583-57-00
5
2025-07-30
HER2-positive locally advanced or metastatic gastric or gastroesophage
-
2024-519521-37-01
10
2025-07-30
Acute ischemic stroke
-
2024-519059-28-00
5
2025-07-17
Chronic Heart Failure
-
2024-516834-36-00
5
2025-07-08
Locally recurrent unresectable or metastatic TNBC with tumors expressi
-
2024-513836-28-00
5
2025-06-23
Chronic Migraine
-
2024-515764-31-00
10
2025-06-13
Non-small cell lung cancer
-
2024-512302-25-00
5
2025-06-06
Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
-
2023-504180-16-00
5
2025-04-07
Advanced Breast Cancer
-
2024-517957-29-00
4
2025-04-02
Mild Cognitive Impairment (MCI)
-
2024-515445-42-00
5
2025-03-24
Node-positive, Estrogen Receptor-positive, HER2-negative, Early Breast
-
2023-508813-18-00
4
2024-12-18
Refractory Focal Onset Epilepsy
-
2024-511319-91-00
5
2024-10-23
Advanced non-small cell lung cancer with HER2 (ERBB2) mutation
-
2023-508811-21-00
10
2024-09-25
Refractory Focal Onset Epilepsy
-
2023-503412-33-00
5
2024-03-29
Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small cell lung cance
-
2023-503708-10-00
5
2024-02-20
Locally advanced or metastatic breast cancer
-
2022-502282-24-00
5
2024-02-14
Primary generalized tonic-clonic seizures
-
2022-502281-25-00
5
2023-09-27
Focal Onset Seizures
-
2023-505438-85-00
5
2022-01-12
Acute myocardial infarction (AMI)
-
2024-512671-12-00
10
2021-03-05
Unresectable head and neck squamous cell carcinoma, metastatic head an
-
2022-501254-10-00
5
2018-08-24
Advanced tumors
-
2025-521067-13-00
5
2026-04-24
Atherosclerotic Cardiovascular Disease (ASCVD)
-
2025-521127-73-00
5
2025-09-12
Relapsing forms of Multiple Sclerosis
-
2025-520521-21-00
5
2025-09-02
Hyperlipidemia
-
2024-512925-95-00
5
2025-05-16
Advanced/Metastatic Breast Cancer